Latest News and Press Releases

NEW YORK, May 06, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of...

NEEDHAM, Mass., March 09, 2020 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a clinical-stage biopharmaceutical company focused on improving the lives of patients with rare and serious chronic...

WALTHAM, Mass., Nov. 01, 2017 (GLOBE NEWSWIRE) -- Chiasma, Inc. (Nasdaq:CHMA), a clinical-stage biopharmaceutical company focused on improving the lives of patients with rare and serious chronic...

WALTHAM, Mass., May 05, 2017 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ:CHMA), a clinical-stage biopharmaceutical company focused on improving the lives of patients with rare and serious chronic...

WILMINGTON, Del., July 25, 2016 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A.: Do you, or did you, own shares of Chiasma, Inc. (NASDAQ:CHMA)?Did you purchase your shares pursuant and/or...

NEW YORK, July 21, 2016 (GLOBE NEWSWIRE) -- Scott + Scott, Attorneys at Law, LLP, a global investor rights law firm, notifies investors that a securities lawsuit has been filed on behalf of...

WILMINGTON, Del., June 16, 2016 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A.: Do you, or did you, own shares of Chiasma, Inc. (NASDAQ:CHMA)?Did you purchase your shares pursuant and/or...

NEW YORK, June 13, 2016 (GLOBE NEWSWIRE) -- Scott+Scott, Attorneys at Law, LLP (“Scott+Scott”), a global investor rights law firm, reminds investors that August 8, 2016 is the last day to file...

NEWTON, Mass., Feb. 29, 2016 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ:CHMA), a late-stage biopharmaceutical company, today announced its support for Rare Disease Day 2016. In honor of Rare...